Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Awad, A. George
1992.
Quality of Life of Schizophrenic Patients on Medications and Implications for New Drug Trials.
Psychiatric Services,
Vol. 43,
Issue. 3,
p.
262.
Lewis, G
and
Booth, M
1992.
Regional differences in mental health in Great Britain..
Journal of Epidemiology & Community Health,
Vol. 46,
Issue. 6,
p.
608.
Shah, Ajit
1992.
The burden of psychiatric disorder in primary care.
International Review of Psychiatry,
Vol. 4,
Issue. 3-4,
p.
243.
Davies, Linda M.
and
Drummond, Michael F.
1993.
Assessment of Costs and Benefits of Drug Therapy for Treatment-Resistant Schizophrenia in the United Kingdom.
British Journal of Psychiatry,
Vol. 162,
Issue. 1,
p.
38.
Shah, Ajit
1993.
The Economic Burden of Psychiatric Illness.
Australasian Psychiatry,
Vol. 1,
Issue. 2,
p.
73.
Menezes, Paulo R.
and
Mann, Anthony H.
1993.
The social adjustment of patients with schizophrenia: implications to the mental health policy in Brazil.
Revista de Saúde Pública,
Vol. 27,
Issue. 5,
p.
340.
Livingston, M.G
1994.
Risperidone.
The Lancet,
Vol. 343,
Issue. 8895,
p.
457.
McCrone, Paul
and
Strathdee, Geraldine
1994.
Needs Not Diagnosis: Towards a More Rational Approach To Community Mental Health Resourcing in Britain.
International Journal of Social Psychiatry,
Vol. 40,
Issue. 2,
p.
79.
Goldberg, D.
1994.
Cost‐effectiveness in the treatment of patients with schizophrenia.
Acta Psychiatrica Scandinavica,
Vol. 89,
Issue. s382,
p.
89.
Davies, Bleddyn
and
Knapp, Martin
1994.
Improving Equity and Efficiency in British Community Care.
Social Policy & Administration,
Vol. 28,
Issue. 3,
p.
263.
Jonsson, Dick
and
Wålinder, Jan
1994.
The socioeconomic cost of treatment of therapy-refractory schizophrenic patients in Sweden.
Nordic Journal of Psychiatry,
Vol. 48,
Issue. 5,
p.
311.
McCrone, Paul
and
Phelan, Michael
1994.
Diagnosis and length of psychiatric in-patient stay.
Psychological Medicine,
Vol. 24,
Issue. 4,
p.
1025.
Davies, Linda M.
and
Drummond, Michael F.
1994.
Economics and Schizophrenia: The Real Cost.
British Journal of Psychiatry,
Vol. 165,
Issue. S25,
p.
18.
Shahz, A.
1995.
The Measurement of the Economic Burden of Psychiatric Illness in Old Age.
Australian Journal on Ageing,
Vol. 14,
Issue. 1,
p.
3.
Jonsson, D.
and
Wålinder, J.
1995.
Cost‐effectiveness of clozapine treatment in therapy‐refractory schizophrenia.
Acta Psychiatrica Scandinavica,
Vol. 92,
Issue. 3,
p.
199.
Bottomley, C.
and
Hallstrom, C.
1995.
Prescribing restrictions for expensive psychiatric drugs.
Psychiatric Bulletin,
Vol. 19,
Issue. 6,
p.
377.
SHEPHERD, GEOFF
1995.
Perspectives on schizophrenia: A survey of user, family carer and professional views regarding effective care.
Journal of Mental Health,
Vol. 4,
Issue. 4,
p.
403.
Larach, V.
Erazo, R.
Bustos, M.
Osorio, R.
Corrales, G.
Pizarro, F.
and
Gallardo, R.
1995.
Cost-benefit of a depot neuroleptic clinic: 10 years' follow-up of functioning of a clinical-administrative model.
Nordic Journal of Psychiatry,
Vol. 49,
Issue. sup35,
p.
57.
Daradkeh, Tewfik K.
El-Rufaie, Omer E.F.
Reda, Fatma
and
Karim, Lina
1996.
Predictors of length of hospital stay.
Nordic Journal of Psychiatry,
Vol. 50,
Issue. 2,
p.
127.
Knapp, MRJ
1996.
Cost-effectiveness in the treatment of schizophrenia.
European Psychiatry,
Vol. 11,
Issue. 3,
p.
137.
eLetters
No eLetters have been published for this article.